Back to Announcements

Microba CSO presents to US industry conference

News

Microba Chief Scientific Officer A/Professor Lutz Krause recently presented to microbiome research and development professionals at the 7th Annual Translational Microbiome Conference.

Running from 13-14 April in Washington, DC, the virtual presentation was delivered on Day One at 4.30 PM 13 April (US EDT) / 6:30 AM on 14 April (AUS EST).

A/Professor Krause detailed how Microba empowers translational research outcomes with precision microbiome analysis and AI (artificial intelligence).

Contact
Associate Professor Lutz Krause
Chief Scientific Officer |
About
Microba Life Sciences is a precision microbiome company driving the discovery and development of novel therapeutics for major chronic diseases to improve human health. With world-leading technology for measuring the human gut microbiome, Microba employs a human-first data-driven approach to identify therapeutic leads which are naturally derived from a healthy human gut. Leveraging a globally unique, proprietary databank, Microba has established a unique, repeatable Therapeutic Platform to address large unmet clinical needs for chronic diseases with microbiome-based treatments.